TTR and familial amyloid neuropathy: RecruitingPrimary outcome measures: rate of progression of TTR cardiac amyloidosis (strain echocardiography)Secondary outcome measures: number of patients with adverse events to the medications over the period of therapy (18 months), evaluate general and health related QoL in senile and familial TTR amyloidosis subjects